You are here: Home » Reuters » News
Business Standard

Sun Pharma says U.S. FDA clears Halol plant

Reuters  |  MUMBAI 

MUMBAI (Reuters) - India's largest drugmaker Sun Pharmaceutical Industries Ltd said on Tuesday the U.S. Food and Drug Administration (FDA) cleared its Halol drug plant, which had been under supply restrictions due to quality control failures.Sun will now be able to restart supplies to its largest market, the United States, from the Halol facility in western India which contributed around 15 percent to the company's U.S. revenue in 2015. The FDA issued the company with a warning letter that year following an inspection that revealed manufacturing quality failures at Halol.The company has been ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Tue, June 12 2018. 17:45 IST